Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELUW) Gross Margin (2020 - 2025)

Historic Gross Margin for Celularity (CELUW) over the last 6 years, with Q3 2025 value amounting to 26.12%.

  • Celularity's Gross Margin fell 321100.0% to 26.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.36%, marking a year-over-year decrease of 508400.0%. This contributed to the annual value of 72.36% for FY2024, which is 426900.0% up from last year.
  • Latest data reveals that Celularity reported Gross Margin of 26.12% as of Q3 2025, which was down 321100.0% from 8.61% recorded in Q2 2025.
  • Celularity's Gross Margin's 5-year high stood at 91.31% during Q3 2021, with a 5-year trough of 967.3% in Q4 2024.
  • In the last 5 years, Celularity's Gross Margin had a median value of 58.23% in 2024 and averaged 5.11%.
  • Within the past 5 years, the most significant YoY rise in Celularity's Gross Margin was 533700bps (2024), while the steepest drop was -9879600bps (2024).
  • Over the past 5 years, Celularity's Gross Margin (Quarter) stood at 70.53% in 2021, then crashed by -102bps to 1.26% in 2022, then surged by 1741bps to 20.67% in 2023, then crashed by -4781bps to 967.3% in 2024, then soared by 103bps to 26.12% in 2025.
  • Its Gross Margin was 26.12% in Q3 2025, compared to 8.61% in Q2 2025 and 68.9% in Q1 2025.